Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
CoAxia |
---|---|
Information provided by: | CoAxia |
ClinicalTrials.gov Identifier: | NCT00119717 |
The purpose of this study is to assess the safety and efficacy of the NeuroFlo™ catheter for use in patients with ischemic stroke. The NeuroFlo device is intended to increase blood flow to the brain and potentially reduce the damage caused by stroke.
Condition | Intervention | Phase |
---|---|---|
Cerebrovascular Accident |
Device: NeuroFlo™ catheter Other: Control |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) |
Estimated Enrollment: | 500 |
Study Start Date: | June 2005 |
Estimated Study Completion Date: | February 2010 |
Estimated Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Device: NeuroFlo™ catheter
45 minute treatment
|
2: Active Comparator |
Other: Control
ASA Guidelines
|
The study is a prospective, controlled, randomized, single-blind, multi-center study of NeuroFlo treatment plus standard medical management versus standard medical management alone. Randomization will be 1:1 and stratified to ensure equivalent patient distribution between treatment and control for the following key parameters:
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: CoAxia | 763-315-1809 |
Principal Investigator: | Ashfaq Shuaib, MD | University of Alberta, Edmonton |
Responsible Party: | University of Alberta, Edmonton ( Ashfaq Shuaib, MD ) |
Study ID Numbers: | CD-0125 |
Study First Received: | July 7, 2005 |
Last Updated: | April 13, 2009 |
ClinicalTrials.gov Identifier: | NCT00119717 History of Changes |
Health Authority: | United States: Food and Drug Administration; Canada: Health Canada; Israel: Ministry of Health |
acute ischemic stroke |
randomized device treatment |
Cerebral Infarction Stroke Vascular Diseases Central Nervous System Diseases Brain Ischemia |
Brain Infarction Ischemia Brain Diseases Infarction Cerebrovascular Disorders |
Cerebral Infarction Nervous System Diseases Stroke Vascular Diseases Central Nervous System Diseases |
Brain Ischemia Cardiovascular Diseases Brain Infarction Brain Diseases Cerebrovascular Disorders |